201
Participants
Start Date
March 28, 2017
Primary Completion Date
February 7, 2019
Study Completion Date
March 23, 2021
Ixekizumab
Administered SC
Placebo
Administered SC
Etanercept
Administered SC
Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, Budapest
RM Pharma Specialists S.A. de C.V., Distrito Federal
Debreceni Egyetem Klinikai Kozpont Borgyogyaszati Klinika, Debrecen
Allergo-Derm Bakos Kft, Szolnok
Fundación Estudios Clínicos- Servicio de Dermatología, Rosario
Oroshaza Varosi Onkormanyzat Korhaza, Orosháza
SZTE AOK Borgyogyaszati es Allergologiai Klinika, Szeged
ISA GmbH, Berlin
Dermatology and Skin Surgery Center, Exton
Children's National Medical Center, Washington D.C.
Virginia Clinical Research, Norfolk
University of North Carolina Dermatology and skin Cancer Cen, Chapel Hill
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Medical University of South Carolina, Charleston
Advanced Medical Research, Sandy Springs
Solutions Through Advanced Research, Inc., Jacksonville
Centre hospitalier universitaire Pellegrin, Bordeaux
University of South Florida, Tampa
Forward Clinical Trials, Inc, Tampa
Olympian Clinical Research, Clearwater
University of Alabama at Birmingham, Birmingham
Ohio State Univ College Of Medicine, Gahanna
Wright State Physicians Dermatology, Fairborn
The South Bend Clinic, South Bend
Universitätsklinikum Münster, Münster
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz
Arlington Dermatology, Rolling Meadows
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt am Main
Northwestern University, Chicago
University of Chicago Medical Center, Chicago
SSM Health Cardinal Glennon Children's Hospital, St Louis
Hospital Univ. Dr. Jose Eleuterio Gonzalez, Monterrey
University of Missouri, Columbia
Hôpital Femme Mère Enfant, Bron
Modern Research Associates PLLC, Dallas
Texas Dermatology and Laser Specialists, San Antonio
Universitätsklinikum Erlangen, Erlangen
Arke Estudios Clinicos S.A. de C.V., Veracruz
Tien Q. Nguyen, MD inc. DBA First OC Dermatology, Fountain Valley
Oregon Dermatology and Research Center, Portland
Oregon Health and Science University, Portland
Center of Children's Health, Moscow
GBUZ Clinical dermatology and venereological dispensary, Krasnodar
Psoriasis Treatment Center of Central New Jersey, East Windsor
Centro de Investigaciones Metabólicas (CINME), Ciudad Autonoma de Buenos Aire
Instituto de Neumonología y Dermatología, Buenos Aires
Psoriahue Medicina Interdisciplinaria, Buenos Aires
Institute for Skin Advancement, Calgary
Lynderm Research Inc, Markham
K. Papp Clinical Research Inc, Waterloo
Hospital Ste Justine, Montreal
Detska fakultni nemocnice, Brno
Fakultni nemocnice Hradec Kralove, Hradec Králové
Fakultni Nemocnice Plzen, Plzen-Bory
Fakultni nemocnice Kralovske Vinohrady, Prague
LF UK - Fakultni poliklinika, Prague
Nemocnice Na Bulovce, Prague
CHU de Nice Hopital de L'Archet, Nice
Hospital Infantil de Mexico, Mexico City
Universitair Medisch Centrum St Radboud Nijmegen, Nijmegen
"Dermed Centrum Medyczne Sp. z o.o.", Lodz
Centralny Szpital Kliniczny MSW, Warsaw
DermMEDICA Sp. z o.o., Wroclaw
Office of Dr. Samuel Sanchez PSC, Caguas
Grupo Dermatologico de Carolina, Carolina
Ponce School of Medicine CAIMED Center, Ponce
GCM Medical Group PSC, San Juan
Hospital Sant Joan de Déu, Esplugues de Llobregat
Eli Lilly and Company
INDUSTRY